--- a
+++ b/clusters/9knumclustersv2/clust_1188.txt
@@ -0,0 +1,94 @@
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= ,/ul
+White blood cell (WBC) >= ,/uL
+White blood cell (WBC) greater than or equal to ,/ul
+White blood cell (WBC) ? . K/uL
+White blood cell count (WBC) > /uL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) > /ul within four weeks of enrollment
+White blood cell (WBC) count >= ,/uL
+White blood cell (WBC) counts > /uL.
+White blood cell count (WBC) >= /uL.
+Obtained within  days prior to randomization/registration: white blood cell (WBC ) >= /uL
+White blood cell (WBC) count of > /ul
+White blood cell (WBC) counts > /uL.
+White blood cell (WBC) count < ,/uL before administration of pevonedistat on cycle  day ; Note: hydroxyurea may be used to control the level of circulating leukemic blast cell counts to not lower than ,/uL during the study
+Obtained within  days of the first study treatment: White blood cell (WBC) count > /uL
+White blood cell (WBC) >= /uL within  days of registration
+Obtained within  days prior to randomization/registration: White blood cell (WBC) >= /uL.
+Obtained within  days of the first study treatment: White blood cell (WBC) count > /uL
+White blood cell (WBC) counts > /uL
+Obtained within  days prior to the first study treatment (cycle , day ): white blood cell (WBC) counts > /uL
+White blood cell (WBC) count of >= /ul
+Leukocytes (white blood cell [WBC]) >= ,/uL
+White blood cell count (WBC) >= /uL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= /uL, within  days before study registration
+Within  days prior to the first study treatment (cycle , day ): White blood cell (WBC) counts > /uL
+White blood cell (WBC) counts > /uL
+Performed within  days (+  working days) prior to registration: White blood cell (WBC) > ,/ul.
+White blood cell count (WBC) >= ,/uL
+Total white blood cell (WBC) count >= /uL, within  days of study registration (within  days for pulmonary and cardiac assessments)
+White blood cell (WBC) counts > /uL within  days prior to the first study treatment (cycle , day )
+White blood cell count (WBC) >= /uL should be obtained within  days prior to enrollment
+White blood cell (WBC) >= /uL
+White blood count (WBC) >= /uL obtained within  days prior to randomization/registration
+White blood cell counts (WBC) > /uL
+Within  days prior to study entry: White blood cell (WBC) >= /uL
+White blood cell count (WBC) >= /uL
+White blood cell (WBC) count > /uL
+Must be met within  days of course  day  (CD): White blood cell (WBC) >= ,/ul
+White blood cell (WBC) >= ,/uL
+White blood cell (WBC) >= ,/uL obtained no more than  days prior to the start of neoadjuvant endocrine therapy
+White blood cell (WBC) >= /uL
+White blood count (WBC) > ,/uL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= ,/ul
+Within  days prior to the first study treatment (cycle , day ): White blood cell (WBC) counts >= /uL.
+WBC (white blood cell count) is /ul
+White blood cell (WBC) >= . x ^/ul
+White blood cell (WBC) less than or equal to /uL
+White blood cell (WBC) counts > /uL, obtained within  days prior to the first study treatment (cycle , day )
+Performed within  days prior to study: White blood count (WBC) > ,/ul
+White blood cell (WBC) >= . x ^/ul
+White blood cell (WBC) >= ,/uL
+White blood cell (WBC) counts > /uL
+White blood cell (WBC) > /ul
+No exclusion for blood counts; however, at the time of treatment initiation, white blood cell (WBC) should be < ,/uL (can be controlled with hydroxyurea)
+White blood cell count (WBC) >= /ul
+White blood cell (WBC) > ,/ul
+White blood cell (WBC) greater than or equal to ,/ul
+White blood cell (WBC) >= /UL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) count >= /ul, obtained within  days prior to initiation of study treatment
+White blood cell (WBC) >= /uL
+White blood cell (WBC) count >= /uL
+White blood cell (WBC) >= /ul
+White blood cell (WBC) count of >= /ul
+White blood cell (WBC) > ,/ul
+White blood cell (WBC) >= ,/ul
+Obtained within  days prior to the first study treatment (cycle , day ); white blood cell (WBC) counts > /uL
+White blood cell (WBC) count of >= /ul
+White blood cell (WBC) >= ,/ul
+Whole blood cell (WBC) >= ,/ul
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) counts > /uL (obtained within  days prior to the first study treatment [course , day ])
+White blood cell (WBC) > /ul
+White blood cell (WBC) > /uL
+White blood cell (WBC): >= /uL (~ x ^/L)
+White blood count (WBC) of >  ul 
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= , /uL
+White blood cell (WBC) >= . K/uL
+White blood cell (WBC) > . K/uL
+White blood cell count (WBC) >= ,/uL
+Total absolute phagocyte count (APC = %neutrophils + %monocytes) X white blood cell (WBC) is at least /uL
+White blood cell (WBC) >= /uL
+White blood cell (WBC) >= ,/uL
+White blood cell (WBC) > . k/uL
+White blood cell (WBC) >= ,/uL
+Leukocytes >= ,/uL; Note: if leukopenia is idiopathic and no other significant co-morbidities exist patients will not be excluded on the basis of their white blood cell (WBC)
+White blood cell count (WBC) >= ,/ul
+White blood cell (WBC) < /uL
+White blood cell (WBC) >= ,/uL, performed within  days prior to registration